** Shares of Innovent Biologics Inc 1801.HK rise 2.8% to HK$55.25 on their second session of gain, on track for the biggest one-day pct gain since April 24
** The Chinese innovative medicines developer and producer says it achieved total product revenue exceeding 2.4 bln yuan ($330.10 mln) for the first quarter of 2025, maintaining over 40% year-on-year growth
** "The year 2025 is a significant year for the company as it enters a new era of growth and global innovation" - Innovent
** Hang Seng Biotech Index .HSHKBIO gains 0.8%, Hang Seng Index .HSI rises 1.5%
** Stock up 50.7% YTD
($1 = 7.2706 Chinese yuan renminbi)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。